Organon & Co

Organon & Co sells prescription drugs across three segments: women's health products (contraceptives, fertility treatments), biosimilars (lower-cost versions of biologic drugs), and a large portfolio of established/off-patent branded medicines spanning cardiovascular, respiratory, and other therapeutic areas. Customers are hospitals, pharmacies, and healthcare systems worldwide. Most revenue comes from the established brands segment — mature products with stable but slowly declining demand. Europe and Canada are the largest markets, followed by the U.S. The company earns money by selling these drugs directly, with biosimilars representing a smaller but growing piece of the business.